The global autoimmune disease therapeutics market is expected to be worth USD 54.8 billion in 2021 and USD 113.48 billion by 2028, with a compound annual growth rate (CAGR) of nearly 12.9% during the forecast period.
Market Overview for Autoimmune Disease Therapeutics
Autoimmune disorders are caused by an autoimmune response that destroys body tissue and targets cells. Autoimmune diseases are almost always fatal, with no long-term cure. There are approximately 80 autoimmune diseases with unknown aetiology around the world. This disease affects approximately 300 million people worldwide, with women constituting 70 to 80% of those affected. The two primary drivers driving market growth are the increasing prevalence of autoimmune diseases and increased awareness of these issues. The rise in
Autoimmune Disease Therapeutics Market: Growth Drivers
The increasing prevalence of autoimmune diseases increased patient awareness and laboratory automation, allowing for the simultaneous diagnosis of multiple diagnostic tests, resulting in faster and more accurate results, all of which contributed to the global autoimmune disease therapy market's growth. As a result, the market expands. The autoimmune disorder causes the destruction of healthy tissues, cells, and organs. It can affect any part of the body, impairing function and posing a threat to one's life.
Read Related: https://www.zionmarketresearch.com/news/global-autoimmune-disease-therapeutics-market
Autoimmune Disease Therapeutics Market: Segmentation
The global autoimmune disease therapeutics market is divided into three sections: drug class, distribution channel, and geography.
By drug class, immunosuppressants, anti-inflammatory drugs, corticosteroids, nonsteroidal anti-inflammatory pharmaceuticals, and biologics dominate. Anti-inflammatory drugs are the market's dominant product, accounting for more than 30% of global sales.
Hospitals, clinics, drug stores, and independent pharmacies are the market's four distribution channels. Over the forecast period, the hospital segment is expected to grow faster.
Competitive Landscape
Some of the main competitors dominating the global autoimmune disease therapeutics market include – Chugai Pharmaceutical Co. Ltd, Amgen Inc, Eli Lilly and Company, Genentech Inc, Elan Corporation Plc, F. Hoffmann-La Roche AG, Squibb Company, Merck Co. Inc, GlaxoSmithKline Plc, Bayer Schering Pharma AG, Biogen Idec Inc, Johnson Johnson Inc, and Abbott Laboratories.
The global autoimmune disease therapeutics market is divided into the following segments:
By Drug Class
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-Inflammatory Drugs
Biologics
By Distribution Channel
Hospitals
Clinics
Drug Stores
Independent Pharmacies
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East Africa
GCC
South Africa
Rest of Middle East Africa
Contact US
Zion Market Research
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL-FREE +1 (855) 465-4651
Email: [email protected]
Read Also:
https://marketandmarkettrade.blogspot.com/2023/02/global-food-waste-management-market.html
https://paperpage.in/blogs/32881/Global-Food-Waste-Management-Market-Size-Share-Growth-Report-2030
